APRIL BURGESS: Open Payments
NPI 1588125298 · FORT WALTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 17 payments from 8 companies in 2025. Trend: 2023 $617 · 2024 $241 · 2025 $830
Food & beverage: $830
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $281 |
| Vanda Pharmaceuticals Inc. | 3 | $162 |
| Janssen Pharmaceuticals, Inc | 2 | $142 |
| Braeburn Inc. | 2 | $133 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| Alkermes, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: CAPLYTA, FANAPT, INVEGA SUSTENNA, BRIXADI, AUSTEDO XR, ARISTADA, REXULTI, UZEDY.
Industry payments across FL — which companies pay providers there.
